Eagle Pharmaceuticals
EGRX
$4.06
Share price
5.45%
Change (1 day)
-78.48%
Change (1 year)
Categories
Market capitalization of Eagle Pharmaceuticals (EGRX)
Market cap: $52.61 Million
As of June 2024 Eagle Pharmaceuticals has a market cap of $52.61 Million. This makes Eagle Pharmaceuticals the world's 7851th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eagle Pharmaceuticals from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $52.61 M | -22.54% |
| 2023 | $67.92 M | -82.15% |
| 2022 | $0.38 B | -42.14% |
| 2021 | $0.65 B | 8.37% |
| 2020 | $0.60 B | -25.9% |
| 2019 | $0.81 B | 46.08% |
| 2018 | $0.56 B | -29.67% |
| 2017 | $0.79 B | -35.08% |
| 2016 | $1.22 B | -11.44% |
| 2015 | $1.38 B | 537.26% |
| 2014 | $0.21 B |
End of Day market cap according to different sources
On Jun 17th, 2024 the market cap of Eagle Pharmaceuticals was reported to be:
$52.61 Million
$52.61 Million
$52.72 Million
$52.72 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $351.25 B | 667,554.42% | 🇺🇸 USA |
 Novartis NVS | $214.24 B | 407,128.24% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $841.11 B | 1,598,670.68% | 🇺🇸 USA |
 Amgen AMGN | $162.69 B | 309,136.08% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $83.05 B | 157,759.40% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $83.45 B | 158,523.36% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $19.39 B | 36,757.42% | 🇮🇱 Israel |